The Michael J. Fox Foundation
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)(Learn how and when to remove this template message)
|Founded||31 October 2000|
|Founder||Michael J. Fox|
|Legal status||501(c)(3) Non-profit|
|Headquarters||New York City|
|Fields||Parkinson's disease clinical research|
|Robert W. Shakleton|
|Mission||To ensure the development of better treatments, and ultimately a cure, for Parkinson's disease through an aggressively funded research agenda.|
The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease (PD) through an aggressively funded research agenda and to ensure the development of improved therapies for those living with Parkinson's today. Established by actor Michael J. Fox in 2000, the Foundation has since become the largest nonprofit funder of Parkinson's disease research in the world, investing more than $650 million in research to date. The Foundation's proactive approach to advancing Parkinson's disease science has made it "the most credible voice on Parkinson's research in the world". In 2010, the Foundation launched the first large scale clinical study on evolution biomarkers of the disease at a cost of $45 million over 5 years.
The Foundation targets people's high-risk, "translational" research—the work of translating basic scientific discoveries into simple treatments with definition to benefit the estimated five million people living with Parkinson's disease today.
The Foundation drives progress by awarding grants to ensure that the most promising research avenues are thoroughly funded, explored and carried forward toward pharmacy shelves. The Foundation's four annually recurring Pipeline Programs aim to speed research along the drug development pipeline. The Pipeline Programs include:
Rapid Response Innovation Awards quickly support high-risk, high-reward projects with little to no existing preliminary data, but potential to significantly impact our understanding or treatment of PD (an Edmond J. Safra Core Program for PD Research).
Target Validation Awards provide support for work demonstrating whether modulation of a novel biological target has impact in a PD-relevant pre-clinical model — an essential step to the development of potential targeted therapies (an Edmond J. Safra Core Program for PD Research).
Clinical Intervention Awards support clinical testing of promising PD therapies that may significantly and fundamentally improve treatment of PD (an Edmond J. Safra Core Program for PD Research).
Therapeutics Development Initiative, an industry-exclusive support program for preclinical development of Parkinson’s disease therapies with potential to fundamentally alter disease course and/or improve treatment of symptoms above and beyond current standards of care.
The Pipeline Programs are complemented by the Foundation's Critical Challenges in Parkinson's Disease program, which provides funds for top research priorities. Critical Challenges in 2009/2010 include: speeding research on PD genetic targets, LRRK2 and alpha-synuclein; advancing research on neurotrophic factors; identifying biomarkers of PD; understanding patient's unmet needs, like postural instability and gait disturbances; and, promoting collaborations with the Arizona Parkinson's Disease Consortium.
Team Fox for Parkinson's Research is the foundation’s grassroots community project raising funds and awareness for Parkinson's disease.
Education and awareness
The Michael J. Fox Foundation publishes a print newsletter, The Fox Focus, two times per year as well as a monthly e-newsletter, FoxFlash, to keep supporters updated on Parkinson's research progress. In 2010, the Foundation launched an audio podcast series on Parkinson's science, hosted by KQED Public Radio Host David Iverson. Living with Parkinson's is the Foundation's online source for information on PD (including an animation about how the brain is affected by Parkinson's), guides for the newly diagnosed and caregivers, stories from people living with the disease and additional resources.
In 2016, it created a raffle to raise awareness for Parkinson's disease and raised $6.75 million through Nike and two auctions in Hong Kong and London. One of the Nike Mags sold for over $ 200, 000.
- "The Michael J. Fox Foundation for Parkinson's Research". Division of Corporations. Delaware Department of State. Accessed on May 18, 2016.
- "Names in the News". Associated Press. March 18, 2000. "My immediate plans are to spend time with my family and hang out. I'll be busy launching my Michael J. Fox Foundation for Parkinson's Research," he said. "I wanted to call it PD Cure but I bounced it off a friend and she said 'Pedicure.'"
- "Form 990: Return of Organization Exempt from Income Tax". The Michael J. Fox Foundation for Parkinson's Research. Guidestar. December 31, 2014.
- The Michael J. Fox Foundation for Parkinson's Research
- Taking Science Personally
- "Michael J. Fox Foundation Launches $45M Parkinson Biomarker Initiative". 2012-09-28.
- Our Research: The Michael J. Fox Foundation
- Funding Opportunities: The Michael J. Fox Foundation
- Pipeline Programs: The Michael J. Fox Foundation
- Critical Challenges: The Michael J. Fox Foundation
- Our Publications: The Michael J. Fox Foundation
- Podcasts: The Michael J. Fox Foundation
- Living with Parkinson's: The Michael J. Fox Foundation
- Rooney, Kyle (21 October 2016). "The Michael J. Fox Foundation does raffle with Nike to raise awareness for Parkinson's disease". Hotnewhiphop. Retrieved 21 October 2016.
- Rooney, Kyle (14 November 2016). "One pair of Nike Mags goes for over $ 200, 000". Hotnewhiphop. Retrieved 14 November 2016.